Toggle navigation
Home
Search
Services
Blog
Contact
About
SIRT1 and BCL6: Dual Biomarkers of Endometriosis and Endometrial Receptivity
Angress, Dan
Cicerodx, Inc., Huntington Beach, CA, United States
Search grants from Dan Angress
Search grants from Cicerodx, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Decision-Making and Episodic Memory in Trajectories to Cannabis Addiction
Adverse effects of RBC transfusions: A unifying hypothesis
Leukotriene Modulation of Leukocyte Function
Improving mass balance and glacier dynamics modeling on Arctic glaciers for better prediction and hindcasting
"Across Space and Time" -- The Interelationship of Technology and Basic Research
Recently added grants:
Cancer Epigenetics: A novel PRC2 Dysregulation Mechanism in Multiple Myeloma
A genotype-phenotype study of tumors from patients with inherited mutations in DNA repair genes
Lung Cancer in Never-smokers: Role of Estrogen and its Metabolites
Identification of USP13 as a therapeutic target for ovarian cancer
Molecular Probes Shed Light on Magnesium Homeostasis
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
4R44HD097750-02
Application #
10028286
Study Section
Special Emphasis Panel (ZHD1)
Program Officer
Tingen, Candace M
Project Start
2020-02-11
Project End
2022-01-31
Budget Start
2020-02-11
Budget End
2021-01-31
Support Year
2
Fiscal Year
2020
Total Cost
Indirect Cost
Institution
Name
Cicerodx, Inc.
Department
Type
DUNS #
081007068
City
Huntington Beach
State
CA
Country
United States
Zip Code
92649
Related projects
NIH 2020
R44 HD
SIRT1 and BCL6: Dual Biomarkers of Endometriosis and Endometrial Receptivity
Angress, Dan / Cicerodx, Inc.
NIH 2019
R44 HD
SIRT1 and BCL6: Dual Biomarkers of Endometriosis and Endometrial Receptivity
Angress, Dan / Cicerodx, Inc.
Comments
Be the first to comment on Dan Angress's grant